Teva mulling acquisition in South Africa - report
"Business Report": Adcock Ingram, South Africa's largest pharmaceutical company, has received acquisition offers.
"Business Report" also mentioned Sanofi SA (Euronext: SAN; NYSE: SNY), Baxter International Inc. (NYSE: BAX), and Reckitt-Benckiser plc (LSE: RB).
Adcock Ingram's products include Panado painkillers and Corenza cold medicine. The company's share price rose 8.9% to 67.50 rand on the Johannesburg Stock Exchange on Friday, its highest level since November 2010, giving a market cap of $1.3 billion.
Adcock Ingram has a marketing and distribution agreement with Merck & Co. (NYSE: MRK) for the sale of non-prescription and hypertension drugs. JPMorgan says that a bidding war for Adcock Ingram could push its share price up to 75.80 rand.
Published by Globes [online], Israel business news - www.globes-online.com - on May 13, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options